Synapse - Sarah A King

Sarah A King

Research Focus

Former Employee. Laboratory Medicine; Pathologist Office Asst I

Recent additions – View all

Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high
Journal Article

Middha, S.; Yaeger, R.; Shia, J.; Stadler, Z. K.; King, S.; Guercio, S.; Paroder, V.; Bates, D. D. B.; Rana, S.; Diaz, L. A. Jr; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas
Journal Article

Liu, S.; Gӧnen, M.; Stadler, Z. K.; Weiser, M. R.; Hechtman, J. F.; Vakiani, E.; Wang, T.; Vyas, M.; Joneja, U.; Al-Bayati, M.; more...
Modern Pathology (2019)

Fulltext@MSK | Save
In colorectal carcinoma (CRC), true tumor cell staining for PD-L1 is uncommon and occurs in sporadic microsatellite-instable tumors with loss of MHC-I
Meeting Abstract

Liu, S.; Vyas, M.; Stadler, Z.; Weiser, M.; King, S.; Hechtman, J.; Vakiani, E.; Klimstra, D.; Shia, J.
Modern Pathology (2018)

Fulltext@MSK | Save

Co-authors at MSK

3

Hechtman
3

Shia
3

Stadler
2

Diaz
2

Guercio
2

Klimstra
2

Liu
2

Saltz
2

Segal
2

Vakiani
2

Weiser
1

Al-Bayati
1

Bates
1

Cercek ...
1

Garcia ...
1

Gonen
1

Joneja
1

Ladanyi
1

Markowitz
1

Middha
1

Ntiamoah
1

Paroder
1

Rana
1

Smith
1

Vyas
1

Wang
1

Yaeger
1

Zehir
1

Zhang

Types of Work

Publications

Modern Pathology (2)
JCO Precision Oncology (1)